• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Artikel
  4. Opposite evolution of pathogenicity driven by in vivo wzc and wcaJ mutations in ST11-KL64 carbapenem-resistant Klebsiella pneumoniae
 
  • Details
  • Full
Options
2023
Journal Article
Title

Opposite evolution of pathogenicity driven by in vivo wzc and wcaJ mutations in ST11-KL64 carbapenem-resistant Klebsiella pneumoniae

Abstract
Aims: To investigate the in vivo evolution of the mucoid-phenotype of ST11-KL64 carbapenem-resistant Klebsiella pneumoniae (CRKP) isolated from the same patients and gain insights into diverse evolution and biology of these strains.
Methods: Whole genome sequencing and bioinformatic analysis were used to determine the mutation involved in the mucoid phenotype of ST11-KL64 CRKP. Gene knockout, bacterial morphology and capsular polysaccharides (CPS) extraction were used to verify the role of wzc and wcaJ in the mucoid phenotypes. Antimicrobial susceptibility, growth assay, biofilm formation, host cell adhesion and virulence assay were used to investigate the pleiotropic role of CPS changes in ST11-KL64 CRKP strains. Results: Mutation of wzc S682N led to hypermucoid phenotype, which had negative impact on bacterial fitness and resulted in reduced biofilm formation and epithelial cell adhesion; while enhanced resistance to macrophage phagocytosis and virulence. Mutations of wcaJ gene led to non-mucoid phenotype with increased biofilm formation and epithelial cell adhesion, but reduced resistance of macrophage phagocytosis and virulence. Using virulence gene knockout, we demonstrated that CPS, rather than the pLVPK-like virulence plasmid, has a greater effect on mucoid phenotypic changes. CPS could be used as a surrogate marker of virulence in ST11-KL64 CRKP strains. Conclusions :ST11-KL64 CRKP strains sacrifice certain advantages to develop pathogenicity by changing CPS with two opposite in vivo evolution strategies.
Author(s)
He, Jintao
Zhejiang University School of Medicine, Hangzhou, China
Shi, Qiucheng
Zhejiang University School of Medicine, Hangzhou, China
Chen, Zhifu
Third Military Medical University, Chongqing, China
Zhang, Wang
Zhejiang University School of Medicine, Hangzhou, China
Lan, Peng
Zhejiang University School of Medicine, Hangzhou, China
Xu, Qingye
Zhejiang University School of Medicine, Hangzhou, China
Hu, Huangdu
Zhejiang University School of Medicine, Hangzhou, China
Chen, Qiong
Zhejiang University School of Medicine, Hangzhou, China
Jianzhong, Fan
Zhejiang University School of Medicine, Hangzhou, China
Jiang, Yan
Zhejiang University School of Medicine, Hangzhou, China
Loh, Belinda Wei-Ching
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Leptihn, Sebastian
Zhejiang University School of Medicine, Hangzhou, China
Zou, Quanming
Third Military Medical University, Chongqing, China
Zhang, Jinyong
Third Military Medical University, Chongqing, China
Yu, Yunsong
Zhejiang University School of Medicine, Hangzhou, China
Hua, Xiaoting
Zhejiang University School of Medicine, Hangzhou, China
Journal
Drug resistance updates  
DOI
10.1016/j.drup.2022.100891
Language
English
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Keyword(s)
  • Carbapenem-resistant

  • Klebsiella pneumoniae

  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024